Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Surface Plasmon Resonance | 14 | 2020 | 277 | 4.040 |
Why?
|
Biosensing Techniques | 11 | 2023 | 608 | 2.400 |
Why?
|
Nanotechnology | 12 | 2017 | 706 | 1.910 |
Why?
|
Fluorodeoxyglucose F18 | 9 | 2018 | 1997 | 1.540 |
Why?
|
Point-of-Care Systems | 8 | 2023 | 1120 | 1.380 |
Why?
|
Exosomes | 3 | 2017 | 402 | 1.250 |
Why?
|
Nanostructures | 7 | 2018 | 590 | 1.200 |
Why?
|
Radiopharmaceuticals | 11 | 2020 | 2731 | 1.180 |
Why?
|
Oxidopamine | 2 | 2016 | 161 | 1.090 |
Why?
|
Positron-Emission Tomography | 18 | 2019 | 6230 | 1.030 |
Why?
|
Nanomedicine | 1 | 2022 | 290 | 0.750 |
Why?
|
Glucose-6-Phosphate | 1 | 2016 | 34 | 0.630 |
Why?
|
Streptavidin | 5 | 2022 | 82 | 0.600 |
Why?
|
Parkinson Disease, Secondary | 1 | 2016 | 126 | 0.590 |
Why?
|
Influenza in Birds | 1 | 2016 | 66 | 0.580 |
Why?
|
Gold | 5 | 2023 | 468 | 0.550 |
Why?
|
RNA | 2 | 2022 | 2709 | 0.530 |
Why?
|
Abdominal Fat | 1 | 2016 | 224 | 0.520 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2020 | 1181 | 0.510 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2014 | 191 | 0.500 |
Why?
|
Photochemotherapy | 1 | 2020 | 829 | 0.500 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2016 | 628 | 0.480 |
Why?
|
Refractometry | 1 | 2013 | 55 | 0.480 |
Why?
|
Optical Phenomena | 2 | 2011 | 108 | 0.470 |
Why?
|
Osteosarcoma | 2 | 2018 | 890 | 0.470 |
Why?
|
Ablation Techniques | 2 | 2014 | 231 | 0.470 |
Why?
|
Parathyroid Neoplasms | 1 | 2014 | 245 | 0.460 |
Why?
|
Influenza A virus | 1 | 2016 | 453 | 0.460 |
Why?
|
Nanoparticles | 5 | 2016 | 1939 | 0.450 |
Why?
|
Holography | 3 | 2018 | 84 | 0.450 |
Why?
|
Microarray Analysis | 3 | 2012 | 780 | 0.440 |
Why?
|
Single-Chain Antibodies | 1 | 2012 | 111 | 0.430 |
Why?
|
Sepsis | 2 | 2023 | 2474 | 0.420 |
Why?
|
Staining and Labeling | 3 | 2022 | 1154 | 0.420 |
Why?
|
Metals | 2 | 2013 | 691 | 0.410 |
Why?
|
Parkinson Disease | 4 | 2022 | 2665 | 0.410 |
Why?
|
Silver | 1 | 2011 | 121 | 0.400 |
Why?
|
Biotin | 3 | 2009 | 272 | 0.400 |
Why?
|
Metal Nanoparticles | 4 | 2022 | 430 | 0.400 |
Why?
|
Polyethylene Glycols | 1 | 2016 | 1180 | 0.400 |
Why?
|
Thyroidectomy | 3 | 2014 | 889 | 0.380 |
Why?
|
Silicon Dioxide | 1 | 2011 | 257 | 0.380 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2019 | 1972 | 0.380 |
Why?
|
Copper Radioisotopes | 4 | 2019 | 89 | 0.370 |
Why?
|
Neural Stem Cells | 2 | 2014 | 897 | 0.360 |
Why?
|
Click Chemistry | 2 | 2019 | 104 | 0.350 |
Why?
|
Peripheral Arterial Disease | 2 | 2016 | 1224 | 0.350 |
Why?
|
Precancerous Conditions | 1 | 2015 | 940 | 0.340 |
Why?
|
Viral Proteins | 1 | 2016 | 1976 | 0.340 |
Why?
|
Pancreatic Neoplasms | 5 | 2020 | 5000 | 0.340 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 932 | 0.340 |
Why?
|
Liposomes | 2 | 2022 | 751 | 0.340 |
Why?
|
Transistors, Electronic | 1 | 2007 | 20 | 0.330 |
Why?
|
Breast Neoplasms | 4 | 2022 | 20058 | 0.320 |
Why?
|
Nerve Net | 2 | 2016 | 2146 | 0.310 |
Why?
|
Hydrogels | 2 | 2022 | 639 | 0.310 |
Why?
|
Antigens | 1 | 2012 | 1511 | 0.290 |
Why?
|
Graphite | 2 | 2016 | 70 | 0.290 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2018 | 430 | 0.280 |
Why?
|
Microfluidic Analytical Techniques | 4 | 2017 | 776 | 0.280 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 34394 | 0.270 |
Why?
|
Thyroid Neoplasms | 3 | 2014 | 2229 | 0.270 |
Why?
|
Spectrum Analysis, Raman | 2 | 2020 | 231 | 0.270 |
Why?
|
Alzheimer Disease | 2 | 2022 | 7224 | 0.260 |
Why?
|
Tropanes | 3 | 2020 | 56 | 0.260 |
Why?
|
Neoplasms | 6 | 2022 | 20515 | 0.260 |
Why?
|
Molecular Imaging | 3 | 2021 | 852 | 0.260 |
Why?
|
Ferric Compounds | 2 | 2016 | 420 | 0.250 |
Why?
|
Hindlimb | 2 | 2016 | 550 | 0.250 |
Why?
|
Deep Brain Stimulation | 2 | 2022 | 675 | 0.250 |
Why?
|
Ovarian Neoplasms | 3 | 2017 | 4737 | 0.250 |
Why?
|
Adenoma | 1 | 2014 | 2113 | 0.250 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2018 | 8998 | 0.240 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1510 | 0.240 |
Why?
|
Thyroglobulin | 2 | 2014 | 118 | 0.240 |
Why?
|
Nanospheres | 1 | 2022 | 21 | 0.240 |
Why?
|
Aptamers, Nucleotide | 2 | 2022 | 156 | 0.230 |
Why?
|
Humans | 56 | 2023 | 715118 | 0.230 |
Why?
|
Permeability | 2 | 2022 | 795 | 0.230 |
Why?
|
Mannose | 1 | 2022 | 124 | 0.230 |
Why?
|
Endoscopy | 1 | 2012 | 1754 | 0.220 |
Why?
|
Radioisotopes | 2 | 2020 | 501 | 0.210 |
Why?
|
Europium | 1 | 2020 | 13 | 0.210 |
Why?
|
Tumor Burden | 2 | 2018 | 1915 | 0.200 |
Why?
|
Equipment Failure Analysis | 4 | 2013 | 872 | 0.200 |
Why?
|
Pentetic Acid | 1 | 2020 | 220 | 0.200 |
Why?
|
Luminescence | 1 | 2020 | 97 | 0.200 |
Why?
|
Brain | 5 | 2022 | 25188 | 0.190 |
Why?
|
Subthalamic Nucleus | 1 | 2022 | 178 | 0.190 |
Why?
|
Lipid Bilayers | 2 | 2012 | 393 | 0.190 |
Why?
|
Chromatography, Gel | 1 | 2020 | 715 | 0.190 |
Why?
|
Female | 33 | 2023 | 377328 | 0.180 |
Why?
|
Molybdenum | 1 | 2018 | 47 | 0.180 |
Why?
|
Sensitivity and Specificity | 8 | 2020 | 14877 | 0.180 |
Why?
|
Organotechnetium Compounds | 1 | 2019 | 155 | 0.180 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2019 | 150 | 0.180 |
Why?
|
Blood Cells | 1 | 2021 | 322 | 0.180 |
Why?
|
Surface Properties | 3 | 2011 | 1192 | 0.180 |
Why?
|
Hospitals, General | 1 | 2023 | 715 | 0.180 |
Why?
|
Microspheres | 3 | 2016 | 800 | 0.180 |
Why?
|
Hyperplasia | 1 | 2022 | 1173 | 0.170 |
Why?
|
Serum Albumin | 2 | 2022 | 682 | 0.170 |
Why?
|
Uncertainty | 1 | 2023 | 643 | 0.170 |
Why?
|
Spectrometry, Fluorescence | 1 | 2020 | 722 | 0.170 |
Why?
|
Pilocarpine | 2 | 2014 | 69 | 0.160 |
Why?
|
Lung Neoplasms | 3 | 2022 | 12566 | 0.160 |
Why?
|
CA-19-9 Antigen | 1 | 2017 | 102 | 0.160 |
Why?
|
Tissue Distribution | 5 | 2019 | 2412 | 0.150 |
Why?
|
Biotinylation | 2 | 2020 | 188 | 0.150 |
Why?
|
Gallium Radioisotopes | 1 | 2017 | 153 | 0.150 |
Why?
|
Cell Fractionation | 1 | 2017 | 289 | 0.150 |
Why?
|
Equipment Design | 5 | 2013 | 3628 | 0.150 |
Why?
|
Albumins | 1 | 2019 | 567 | 0.150 |
Why?
|
Nanotubes, Carbon | 2 | 2007 | 76 | 0.150 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2018 | 322 | 0.150 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 4924 | 0.150 |
Why?
|
Birds | 1 | 2016 | 154 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2019 | 576 | 0.140 |
Why?
|
Mandibular Neoplasms | 1 | 2016 | 133 | 0.140 |
Why?
|
Heterocyclic Compounds | 1 | 2017 | 273 | 0.140 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2017 | 120 | 0.140 |
Why?
|
Feasibility Studies | 2 | 2016 | 4916 | 0.140 |
Why?
|
Kinetics | 4 | 2012 | 6802 | 0.140 |
Why?
|
Biliary Tract | 1 | 2015 | 139 | 0.140 |
Why?
|
Animals | 21 | 2022 | 170733 | 0.140 |
Why?
|
Micelles | 1 | 2015 | 220 | 0.130 |
Why?
|
Iodine Radioisotopes | 3 | 2014 | 1029 | 0.130 |
Why?
|
Oxides | 1 | 2016 | 425 | 0.130 |
Why?
|
Algorithms | 6 | 2022 | 13669 | 0.130 |
Why?
|
Biopsy, Fine-Needle | 4 | 2022 | 1063 | 0.130 |
Why?
|
Microfluidics | 2 | 2017 | 618 | 0.130 |
Why?
|
Cell Line, Tumor | 6 | 2022 | 16939 | 0.130 |
Why?
|
Muscarinic Agonists | 1 | 2014 | 88 | 0.130 |
Why?
|
Ascitic Fluid | 1 | 2014 | 198 | 0.130 |
Why?
|
Lasers | 2 | 2009 | 955 | 0.120 |
Why?
|
Basal Ganglia | 1 | 2017 | 551 | 0.120 |
Why?
|
Preoperative Period | 1 | 2016 | 557 | 0.120 |
Why?
|
Receptor, IGF Type 1 | 1 | 2016 | 403 | 0.120 |
Why?
|
Molecular Probe Techniques | 1 | 2014 | 117 | 0.120 |
Why?
|
Scattering, Radiation | 2 | 2013 | 524 | 0.120 |
Why?
|
Data Collection | 1 | 2023 | 3293 | 0.120 |
Why?
|
Mice, Inbred BALB C | 3 | 2019 | 6676 | 0.120 |
Why?
|
Image Enhancement | 4 | 2018 | 2978 | 0.120 |
Why?
|
Functional Laterality | 1 | 2020 | 2299 | 0.120 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2020 | 1506 | 0.110 |
Why?
|
Genes, myc | 1 | 2014 | 405 | 0.110 |
Why?
|
Oximes | 1 | 2014 | 318 | 0.110 |
Why?
|
Bacterial Typing Techniques | 1 | 2013 | 285 | 0.110 |
Why?
|
Reproducibility of Results | 5 | 2021 | 19497 | 0.110 |
Why?
|
Mice | 11 | 2022 | 80997 | 0.110 |
Why?
|
Proteins | 3 | 2017 | 6163 | 0.110 |
Why?
|
Radionuclide Imaging | 2 | 2017 | 2034 | 0.110 |
Why?
|
Male | 22 | 2022 | 351080 | 0.110 |
Why?
|
Thyrotropin | 2 | 2014 | 821 | 0.110 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 320 | 0.110 |
Why?
|
Cell-Derived Microparticles | 1 | 2013 | 164 | 0.110 |
Why?
|
Alphapapillomavirus | 1 | 2015 | 227 | 0.110 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2014 | 298 | 0.110 |
Why?
|
Glycolysis | 1 | 2016 | 818 | 0.110 |
Why?
|
Biological Assay | 1 | 2015 | 658 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20397 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2154 | 0.100 |
Why?
|
Luminescent Measurements | 1 | 2013 | 377 | 0.100 |
Why?
|
Drug Delivery Systems | 2 | 2021 | 2234 | 0.100 |
Why?
|
Lipids | 1 | 2022 | 3263 | 0.100 |
Why?
|
Lymphatic Metastasis | 2 | 2016 | 2971 | 0.100 |
Why?
|
Organ Size | 1 | 2016 | 2313 | 0.100 |
Why?
|
Biomimetic Materials | 1 | 2012 | 178 | 0.100 |
Why?
|
Aluminum Oxide | 1 | 2010 | 41 | 0.100 |
Why?
|
Antioxidants | 1 | 2018 | 1689 | 0.100 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2014 | 377 | 0.100 |
Why?
|
Thalamus | 1 | 2017 | 1007 | 0.100 |
Why?
|
Myocarditis | 1 | 2017 | 680 | 0.100 |
Why?
|
Artificial Intelligence | 1 | 2022 | 1728 | 0.100 |
Why?
|
Observer Variation | 1 | 2016 | 2680 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2020 | 6137 | 0.090 |
Why?
|
Optical Devices | 1 | 2009 | 37 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2861 | 0.090 |
Why?
|
Prognosis | 4 | 2018 | 29167 | 0.090 |
Why?
|
Models, Molecular | 2 | 2010 | 5535 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2018 | 3421 | 0.090 |
Why?
|
Particle Size | 1 | 2013 | 1695 | 0.090 |
Why?
|
Myelin Sheath | 1 | 2012 | 649 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2015 | 878 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1632 | 0.080 |
Why?
|
Cytokines | 1 | 2023 | 7226 | 0.080 |
Why?
|
Membrane Lipids | 1 | 2009 | 255 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 2043 | 0.080 |
Why?
|
Neuralgia | 1 | 2013 | 520 | 0.080 |
Why?
|
Computer Simulation | 3 | 2010 | 6075 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2018 | 2536 | 0.080 |
Why?
|
Amyloidosis | 1 | 2014 | 797 | 0.080 |
Why?
|
Lymphoma | 1 | 2016 | 1889 | 0.080 |
Why?
|
Time Factors | 4 | 2020 | 41082 | 0.080 |
Why?
|
Heterocyclic Compounds, 1-Ring | 2 | 2017 | 59 | 0.080 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 2331 | 0.080 |
Why?
|
RNA, Messenger | 1 | 2022 | 13293 | 0.080 |
Why?
|
Pattern Recognition, Automated | 1 | 2013 | 1017 | 0.080 |
Why?
|
Ischemia | 1 | 2016 | 1939 | 0.080 |
Why?
|
Electrochemistry | 1 | 2006 | 157 | 0.080 |
Why?
|
Silicon | 1 | 2007 | 135 | 0.080 |
Why?
|
DNA | 3 | 2022 | 7159 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1890 | 0.070 |
Why?
|
Isotope Labeling | 2 | 2019 | 436 | 0.070 |
Why?
|
Electric Impedance | 1 | 2010 | 655 | 0.070 |
Why?
|
Amygdala | 1 | 2014 | 1273 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1488 | 0.070 |
Why?
|
Injections | 1 | 2009 | 875 | 0.070 |
Why?
|
Subtraction Technique | 1 | 2009 | 546 | 0.070 |
Why?
|
Middle Aged | 12 | 2020 | 214868 | 0.070 |
Why?
|
Cell Membrane | 2 | 2016 | 3912 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11191 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2016 | 7051 | 0.070 |
Why?
|
Antibodies, Viral | 1 | 2016 | 2986 | 0.070 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2008 | 388 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3705 | 0.070 |
Why?
|
Robotics | 1 | 2011 | 867 | 0.060 |
Why?
|
Electrodes | 1 | 2006 | 597 | 0.060 |
Why?
|
Erythrocytes | 1 | 2013 | 2421 | 0.060 |
Why?
|
Oxidation-Reduction | 1 | 2010 | 2334 | 0.060 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 1652 | 0.060 |
Why?
|
Postoperative Period | 2 | 2022 | 1854 | 0.060 |
Why?
|
Autoantibodies | 1 | 2012 | 1993 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2009 | 827 | 0.060 |
Why?
|
Microscopy, Electron, Scanning | 3 | 2011 | 995 | 0.060 |
Why?
|
Adult | 7 | 2018 | 212128 | 0.060 |
Why?
|
Blood Circulation Time | 1 | 2022 | 12 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2014 | 1829 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11766 | 0.060 |
Why?
|
Aged | 9 | 2020 | 162672 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4010 | 0.060 |
Why?
|
Temperature | 1 | 2009 | 2158 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5258 | 0.060 |
Why?
|
Prospective Studies | 4 | 2020 | 51182 | 0.060 |
Why?
|
Bacteria | 1 | 2013 | 2083 | 0.060 |
Why?
|
Receptors, CCR1 | 1 | 2021 | 33 | 0.050 |
Why?
|
Glucose Transporter Type 3 | 1 | 2021 | 16 | 0.050 |
Why?
|
Pyridines | 1 | 2014 | 2867 | 0.050 |
Why?
|
Inflammation | 2 | 2021 | 10085 | 0.050 |
Why?
|
Hippocampus | 1 | 2014 | 3654 | 0.050 |
Why?
|
Uric Acid | 1 | 2006 | 737 | 0.050 |
Why?
|
Receptors, Formyl Peptide | 1 | 2021 | 157 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5234 | 0.050 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2020 | 128 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8671 | 0.050 |
Why?
|
Databases, Nucleic Acid | 1 | 2021 | 213 | 0.050 |
Why?
|
Folate Receptors, GPI-Anchored | 1 | 2019 | 26 | 0.050 |
Why?
|
Dimethylpolysiloxanes | 2 | 2011 | 144 | 0.050 |
Why?
|
Liver | 1 | 2015 | 7647 | 0.050 |
Why?
|
Epilepsy | 1 | 2014 | 2923 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5482 | 0.050 |
Why?
|
Human papillomavirus 18 | 1 | 2019 | 128 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2021 | 852 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2018 | 2148 | 0.040 |
Why?
|
Young Adult | 2 | 2018 | 56155 | 0.040 |
Why?
|
Telemedicine | 1 | 2015 | 2612 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2018 | 378 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 2014 | 8602 | 0.040 |
Why?
|
Half-Life | 1 | 2019 | 686 | 0.040 |
Why?
|
Immunoassay | 1 | 2022 | 764 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15258 | 0.040 |
Why?
|
Mice, Nude | 2 | 2016 | 3825 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3673 | 0.040 |
Why?
|
Rats | 4 | 2017 | 25090 | 0.040 |
Why?
|
Human papillomavirus 16 | 1 | 2019 | 268 | 0.040 |
Why?
|
Drug Carriers | 1 | 2022 | 691 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 8925 | 0.040 |
Why?
|
Chelating Agents | 1 | 2019 | 404 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2016 | 72253 | 0.040 |
Why?
|
Macrophages | 2 | 2022 | 5807 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58503 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2017 | 3010 | 0.040 |
Why?
|
Zirconium | 1 | 2016 | 100 | 0.040 |
Why?
|
Putamen | 1 | 2017 | 299 | 0.040 |
Why?
|
Doxorubicin | 1 | 2022 | 2233 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2017 | 245 | 0.040 |
Why?
|
Obesity | 1 | 2018 | 12195 | 0.030 |
Why?
|
Caudate Nucleus | 1 | 2017 | 402 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2016 | 293 | 0.030 |
Why?
|
Pathology, Molecular | 1 | 2018 | 346 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 382 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9765 | 0.030 |
Why?
|
Lipoproteins | 1 | 2020 | 921 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22941 | 0.030 |
Why?
|
Convulsants | 1 | 2014 | 70 | 0.030 |
Why?
|
Luciferases, Firefly | 1 | 2014 | 40 | 0.030 |
Why?
|
Child | 2 | 2022 | 74147 | 0.030 |
Why?
|
Nucleus Accumbens | 1 | 2017 | 361 | 0.030 |
Why?
|
DNA Ligases | 1 | 2014 | 85 | 0.030 |
Why?
|
Luminescent Agents | 1 | 2014 | 32 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2016 | 467 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1693 | 0.030 |
Why?
|
Amides | 1 | 2017 | 458 | 0.030 |
Why?
|
Benzothiazoles | 1 | 2014 | 251 | 0.030 |
Why?
|
Kidney | 2 | 2019 | 6903 | 0.030 |
Why?
|
Molecular Probes | 1 | 2015 | 323 | 0.030 |
Why?
|
Electromagnetic Fields | 1 | 2015 | 306 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2019 | 1144 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1408 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18345 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13731 | 0.030 |
Why?
|
Radiography | 2 | 2014 | 6994 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2014 | 452 | 0.030 |
Why?
|
Folic Acid | 1 | 2019 | 1245 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2016 | 856 | 0.030 |
Why?
|
Erythrocyte Membrane | 1 | 2013 | 444 | 0.030 |
Why?
|
Malaria | 1 | 2021 | 1082 | 0.030 |
Why?
|
Radiotherapy | 1 | 2019 | 1623 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 13267 | 0.030 |
Why?
|
Limbic System | 1 | 2014 | 440 | 0.030 |
Why?
|
Monocytes | 1 | 2021 | 2661 | 0.030 |
Why?
|
G(M1) Ganglioside | 1 | 2011 | 93 | 0.030 |
Why?
|
Radiometry | 1 | 2017 | 818 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2019 | 2412 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2016 | 1326 | 0.030 |
Why?
|
Neocortex | 1 | 2014 | 385 | 0.020 |
Why?
|
Magnetics | 1 | 2013 | 643 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3970 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3526 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3072 | 0.020 |
Why?
|
Neck Dissection | 1 | 2011 | 219 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6565 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12477 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2014 | 961 | 0.020 |
Why?
|
Enzymes | 1 | 2011 | 276 | 0.020 |
Why?
|
Reference Standards | 1 | 2013 | 997 | 0.020 |
Why?
|
Phospholipids | 1 | 2013 | 813 | 0.020 |
Why?
|
Adolescent | 1 | 2018 | 85001 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16373 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2013 | 909 | 0.020 |
Why?
|
Cholera Toxin | 1 | 2011 | 552 | 0.020 |
Why?
|
Oligodendroglia | 1 | 2012 | 514 | 0.020 |
Why?
|
Species Specificity | 1 | 2013 | 2621 | 0.020 |
Why?
|
Microscopy, Atomic Force | 1 | 2008 | 252 | 0.020 |
Why?
|
Computer-Aided Design | 1 | 2009 | 266 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1331 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 8010 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1501 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2013 | 1258 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3693 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2014 | 1205 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2012 | 1531 | 0.020 |
Why?
|
Thiazoles | 1 | 2014 | 1515 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3508 | 0.020 |
Why?
|
Cicatrix | 1 | 2011 | 693 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2022 | 62186 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2011 | 797 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1838 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 2930 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 6922 | 0.020 |
Why?
|
Propensity Score | 1 | 2011 | 1743 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2013 | 2121 | 0.020 |
Why?
|
Registries | 1 | 2020 | 8090 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3433 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8738 | 0.020 |
Why?
|
Pilot Projects | 1 | 2017 | 8043 | 0.020 |
Why?
|
Ascorbic Acid | 1 | 2006 | 638 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4688 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 16011 | 0.010 |
Why?
|
Antibodies | 1 | 2011 | 2445 | 0.010 |
Why?
|
Light | 1 | 2009 | 1444 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2013 | 3163 | 0.010 |
Why?
|
Echocardiography | 1 | 2014 | 5098 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 13316 | 0.010 |
Why?
|
Water | 1 | 2007 | 1335 | 0.010 |
Why?
|
Carcinoma | 1 | 2011 | 2325 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12488 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 41183 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 18734 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9893 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23510 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9660 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 21789 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4434 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9584 | 0.010 |
Why?
|
Melanoma | 1 | 2016 | 5274 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 20101 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2009 | 3562 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 70705 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 39804 | 0.010 |
Why?
|